Proteasome inhibitors

Kyprolis 30 mg lyophilized powder for injection Images

Generic Name: carfilzomib

This medication has been identified as Kyprolis 30 mg lyophilized powder for injection. It is supplied by Onyx Pharmaceuticals, Inc.

Kyprolis is used in the treatment of Multiple Myeloma and belongs to the drug class proteasome inhibitors. There is positive evidence of human fetal risk during pregnancy. Kyprolis 30 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Kyprolis (Carfilzomib [ kar-filz-oh-mib ])-30 mg lyophilized powder for injection

Kyprolis
Generic Name: carfilzomib [ kar-filz-oh-mib ]
Imprint: N/A
Strength: 30 mg lyophilized powder for injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Proteasome inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 76075-0102
Inactive Ingredients:
Latest News
Related Drugs